Phase 4 N=97 A Comparison of Polyglactin 910 and Chromic Gut Suture in the Closure of Punch Biopsy Sites
Wound Closure Technique
Primary: Presence of Scarring — 1; 1 participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=45 Nebivolol, Lifestyle Modification and Arterial Stiffness
Hypertension
Primary: Beta-stiffness Index — -2.03; -1.87; -2.51 Arbitrary units
Phase 4 N=302 Evaluation of the Long-term Persistence of Immunity to Hepatitis B, in Adolescents Vaccinated in Infancy With Engerix™-B Kinder
Hepatitis B
Primary: Number of Subjects With Anti-hepatitis B Surface Antigen (Anti-HBs) Antibody Concentrations Equal to or Above the Cut Off Value. — 265 Participants
Phase 4 N=12 Study to Assess Eradication of Nasal Carriage of Staphylococcus Aureus (SA) With Mupirocin (Bactroban 2% Nasal Ointment)
Staphylococcal Infection
Primary: Apparent Eradication of Nasal Carriage of SA — 9 participants
Phase 4 N=156 Study of Efficacy and Safety of Vildagliptin as add-on Insulin Therapy in T2DM Patients
Type 2 Diabetes Mellitus (T2DM)
Primary: Change From Baseline in Glycosylated Hemoglobin (HbA1c) at 12 Weeks Between Treatment Groups — -1.01; -0.11 percentage of glycosylated haemoglobin — p=< 0.001
Phase 4 N=15 Pregabalin and Post-thoracotomy Pain
Chronic Pain
Primary: The Primary Outcome Measure for the Final Study Will be the Incidence of CPTPS at 2 Months.
Phase 4 N=300 Patient Preference Study of Fluticasone Furoate and Mometasone Furoate Nasal Sprays
Rhinitis, Allergic, Perennial and Seasonal
Primary: Number of Participants With Overall Preference for Nasal Spray Assessed by Preference Questionnaire. — 96; 59; 30; 57 Participants — p=<0.001
Phase 4 N=36 Combined Mirtazapine and SSRI Treatment of PTSD: A Placebo-Controlled Trial
Posttraumatic Stress Disorder
Primary: PTSD Severity — 23.8; 34.6 units on a scale — p=0.17
Phase 4 N=20 Desensitization in Kidney Transplantation
HLA Sensitization
Primary: Number of Living Donor Transplant Candidates That Are Transplanted — 19 participants
Phase 4 N=955 Prospective Trial of Tranexamic Acid in Cardiac Surgery
C.Surgical Procedure; Cardiac
Primary: Postoperative Blood Loss — 520; 490; 450 ml
Phase 4 N=131 Randomized Study of Immune Response to Licensed Influenza Vaccines in Children and Adolescents
Immune Response to Influenza Vaccine · Influenza A Virus Infection · Influenza B Virus Infection
Primary: Hemagglutination Inhibition (HI) Titer Response to Vaccine and Circulating Strains of Influenza — 99; 295; 96; 100 Titers
Phase 4 N=606 Study on Efficacy and Safety of Chondroitin Sulfate + Glucosamine Hydrochloride Versus Celecoxib in Knee Osteoarthritis
Knee Osteoarthritis
Primary: WOMAC Pain Subscale — 185.79; 184.67 units on a scale
Phase 4 N=79 Meropenem Dosage Strategy Based on PPK Model
Lower Respiratory Tract Infection
Primary: Clinical Success Rate — 28; 35 participants
Phase 4 N=237 A Study of the Efficacy and Safety of Synvisc® in Chinese Subjects With Symptomatic Osteoarthritis of the Knee(s)
Osteoarthritis
Primary: Change From Baseline in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) A1 Subscore (Walking Pain) at Week 26 — -33.0 mm — p=<0.0001
Phase 4 N=74 MRI and Neurodevelopment in Preterm Infants Following Administration of High-Dose Caffeine
Apnea of Prematurity · Intraventricular Hemorrhage · Brain Injury
Primary: White Matter Microstructural Maturation — 1.43; 1.42 apparent diffusion coefficient